Organoid Models: Revolutionizing Personalized Cancer Immunotherapy
Journal: Cell Death Discovery
Author: Qian Wang et al., China
Organoid models provide three-dimensional simulation of tumor microenvironments while preserving heterogeneity, enhancing immunotherapy development. These advanced co-culture systems predict patient responses and reveal immune evasion mechanisms, poised to transform precision medicine when integrated with AI.
Brain Region Diversity Unlocked in Lab-Grown Organoids
Journal: Cell Stem Cell
Author: Soraya Scuderi et al., USA
The Duo-MAPS diffusion device exposes stem cells to orthogonal gradients of WNT and SHH signaling, generating diverse neuronal lineages from forebrain, midbrain, and hindbrain regions. This breakthrough demonstrates how morphogen gradients could model the entire brain, despite variations between cell lines.
Stem Cell Insights Drive Revolutionary Cellular Reprogramming
Journal: Science
Author: Magdalena Götz et al., Germany
Stem cell research has inspired direct cellular reprogramming approaches that leverage developmental fate determinants to convert cells for repair. This knowledge has enabled breakthrough treatments for diabetes, macular degeneration, epilepsy, and Parkinson’s disease, even leading to unexpected applications like cancer cell reprogramming.
Engineered iPSC-Derived NK Cells: A New Weapon Against Solid Tumors
Journal: Science Advances
Author: Qun Jiang et al., USA
Researchers engineered iPSCs with mesothelin-targeting CAR and IL-15, producing robust NK cells with enhanced tumor-killing ability. These cells maintain activation in challenging tumor microenvironments by resisting suppressive factors, offering new hope for treating resistant solid tumors.